Article Versions Notes

Strobel H, Baisch T, Fitzel R, Schilberg K, Siegelin MD, Karpel-Massler G, Debatin K-M, Westhoff M-A. Temozolomide and Other Alkylating Agents in Glioblastoma Therapy. Biomedicines. 2019; 7(3):69. https://doi.org/10.3390/biomedicines7030069

Strobel, Hannah, Tim Baisch, Rahel Fitzel, Katharina Schilberg, Markus D. Siegelin, Georg Karpel-Massler, Klaus-Michael Debatin, and Mike-Andrew Westhoff. 2019. "Temozolomide and Other Alkylating Agents in Glioblastoma Therapy" Biomedicines 7, no. 3: 69. https://doi.org/10.3390/biomedicines7030069

Strobel, H., Baisch, T., Fitzel, R., Schilberg, K., Siegelin, M. D., Karpel-Massler, G., Debatin, K.-M., & Westhoff, M.-A. (2019). Temozolomide and Other Alkylating Agents in Glioblastoma Therapy. Biomedicines, 7(3), 69. https://doi.org/10.3390/biomedicines7030069